Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-31

Clinical Trial Update: Transplantation of Uncontrolled DCD Kidneys REconditioned by a Novel Ex-VIVo Perfusion MEthod [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating reconditioning of uncontrolled DCD kidneys using a novel ex-vivo perfusion method for transplantation in end-stage kidney…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unspecified novel ex-vivo perfusion method

Snippet

Sponsor: Sahlgrenska University Hospital | Conditions: End-Stage Kidney Disease | Phase 1, Phase 2 | Status: UNKNOWN